"Official medicines" is the best online drugstore.World’s leading meds delivered to your door – and you don’t even need a prescription! Only certified, first class drugs on offer! Buy more and spend less with our great discount system. The meds you need, reliable and hassle free! Top products of top brands.The only pharmacy shop you will ever need! Approved drugs available without prescription. Best deals, unmatched service and shipping. 100% safe! |
| (dih-JOX-in) |
Digitek, Lanoxicaps, Lanoxin, Novo-Digoxin |
| Class: Cardiac glycoside |
Action Increases force and velocity of myocardial systolic contraction (positive inotropic action), slows heart rate, and decreases conduction through atrioventricular node.
Indications Treatment of CHF, atrial fibrillation, atrial flutter, paroxysmal atrial tachycardia, cardiogenic shock.
Contraindications Ventricular fibrillation; ventricular tachycardia except in certain cases; digitalis toxicity; beriberi heart disease; hypersensitivity to digoxin; some cases of hypersensitive carotid sinus syndrome.
ADULTS: Rapid digitalization with loading dose: IV 0.4 to 0.6 mg or PO tablets 0.5 to 0.75 mg or capsules 0.4 to 0.6 mg in previously undigitalized patients; additional doses may be given cautiously at 6 to 8 hr intervals (IV 0.1 to 0.3 mg or PO tablets 0.125 to 0.375 mg or capsules 0.1 to 0.3 mg) until clinical response is achieved; thereafter adjust dosage based on levels (usual range 0.125 to 0.5 mg/day as single daily dose). In previously digitalized patients, adjust dosage in proportion to ratio of desired vs current serum levels. INFANTS & CHILDREN: Rapid digitalization with loading dose: Individualize dosage. Usual pediatric doses are listed at end of section.
Amiodarone, anticholinergics, bepridol, benzodiazepines, ACE inhibitors, clarithromycin, cyclosporine, diltiazem, erythromycin, indomethacin, itraconazole, propafenone, quinidine, quinine, tetracycline, verapamil: May increase digoxin serum levels. Antacids, antineoplastics, cholestyramine, colestipol, kaolin/pectin, metoclopramide: May decrease absorption and effect of digoxin. Penicillamine: May decrease effect of digoxin. Potassium-sparing diuretics: May alter effect of digoxin. Thiazide or loop diuretics: May increase effect of digoxin. St. John’s wort, thyroid hormones, thioamines: May decrease effect of digoxin.
Lab Test Interferences None well documented.
CV: Arrhythmias (supraventricular arrhythmias are more common in infants and children), including ventricular tachycardia and premature ventricular contractions. CNS: Headache; weakness; apathy; drowsiness; mental depression; confusion; disorientation. EENT: Visual disturbances (blurred vision, halo effect). GI: Anorexia; nausea; vomiting; diarrhea.
Pregnancy: Category C. Lactation: Excreted in breast milk. Children: Newborns show varying tolerance. Premature and immature infants are particularly sensitive; reduce and individualize dose as needed. Elderly: Use with caution; renal clearance likely to be reduced. Cardiovascular disease: Electrical conversion of arrhythmias may require dose reduction. Digitalis toxicity: Anorexia, nausea, and vomiting may be associated with toxicity or CHF. Arrhythmias for which digoxin is indicated may also be a reflection of toxicity. Impaired renal function: Excretion may be decreased, leading to digoxin accumulation and toxicity; adjust dosage. Electrolyte imbalance: Maintain normal serum potassium, calcium, and magnesium levels. Lanoxicaps: Have greater bioavailability than standard tablets. The 0.2 mg capsule is equivalent to 0.25 mg tablet; the 0.1 mg capsule to 0.125 mg tablet; the 0.05 mg capsule to 0.0625 mg tablet.
| Table. Usual Pediatric Digitalizing and Maintenance Dosages with Normal Renal Function Based on Lean Body Weight | |||
| Age | Digitalizing Dose (mcg/kg) | Daily Maintenance Dose as % of Loading Dose (mcg/kg in 2 to 3 divided doses) | |
| PO | IV | ||
| Premature | 20 to 30 | 15 to 25 | 20% to 30% |
| Term | 25 to 35 | 20 to 30 | 25% to 35% |
| 1 to 24 mo | 35 to 60 | 30 to 50 | 25% to 35% |
| 2 to 5 yr | 30 to 40 | 25 to 35 | 25% to 35% |
| 5 to 10 yr | 20 to 35 | 15 to 30 | 25% to 35% |
| > 10 yr | 10 to 15 | 8 to 12 | 25% to 35% |
| PATIENT CARE CONSIDERATIONS |
|
|
||||
Popularity: 4% [?]
RSS feed for comments on this post · TrackBack URI
Leave a reply